anacardic acid has been researched along with Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| da Silva, SR; Gunning, PT; Lukkarila, JL; Paiva, SL | 1 |
| Hua, D; Wu, X | 1 |
| Fernandez, HR; Lindén, SK | 1 |
| Horibe, T; Kawakami, K; Okuno, Y; Torisawa, A | 1 |
| Harsha Raj, M; Rössler, J; Salimath, BP; Yashaswini, B | 1 |
| Ma, E; Park, WJ | 1 |
| Chen, S; Jiang, X; Price, BD; Sun, Y | 1 |
2 review(s) available for anacardic acid and Neoplasms
| Article | Year |
|---|---|
Exploring a new frontier in cancer treatment: targeting the ubiquitin and ubiquitin-like activating enzymes.
Topics: Animals; Antineoplastic Agents; Humans; Molecular Targeted Therapy; Neoplasms; Ubiquitin; Ubiquitin-Activating Enzymes | 2013 |
Small-molecule inhibitors targeting small ubiquitin-like modifier pathway for the treatment of cancers and other diseases.
Topics: Humans; Neoplasms; Protein Processing, Post-Translational; Small Ubiquitin-Related Modifier Proteins; Sumoylation; Ubiquitin | 2022 |
5 other study(ies) available for anacardic acid and Neoplasms
| Article | Year |
|---|---|
The aspirin metabolite salicylate inhibits lysine acetyltransferases and MUC1 induced epithelial to mesenchymal transition.
Topics: Anacardic Acids; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Lysine Acetyltransferases; Male; Mucin-1; Neoplasms; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Salicylates | 2017 |
Discovery of protein disulfide isomerase P5 inhibitors that reduce the secretion of MICA from cancer cells.
Topics: Aminosalicylic Acids; Anacardic Acids; Benzenesulfonates; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; HCT116 Cells; HeLa Cells; Histocompatibility Antigens Class I; Humans; Molecular Docking Simulation; Neoplasms; Protein Disulfide-Isomerases; Structure-Activity Relationship | 2014 |
Combinatorial treatment with anacardic acid followed by TRAIL augments induction of apoptosis in TRAIL resistant cancer cells by the regulation of p53, MAPK and NFκβ pathways.
Topics: Anacardic Acids; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; Liposomes; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinases; Neoplasms; NF-kappa B; Receptors, TNF-Related Apoptosis-Inducing Ligand; RNA, Messenger; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand; Tumor Suppressor Protein p53; Up-Regulation | 2016 |
Inhibition of PCAF histone acetyltransferase and cytotoxic effect of N-acylanthranilic acids.
Topics: Anacardic Acids; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Enzyme Inhibitors; Humans; Neoplasms; ortho-Aminobenzoates; p300-CBP Transcription Factors; Structure-Activity Relationship | 2012 |
Inhibition of histone acetyltransferase activity by anacardic acid sensitizes tumor cells to ionizing radiation.
Topics: Anacardic Acids; Ataxia Telangiectasia Mutated Proteins; Cell Cycle Proteins; Cell Line, Tumor; DNA-Activated Protein Kinase; DNA-Binding Proteins; Enzyme Inhibitors; HeLa Cells; Histone Acetyltransferases; Humans; Lysine Acetyltransferase 5; Neoplasms; Protein Serine-Threonine Kinases; Radiation-Sensitizing Agents; Radiation, Ionizing; Tumor Suppressor Proteins | 2006 |